MedTrace Logo

Pharmacokinetic Test of High-fat Diet After Oral Administration of SHR2554 in Healthy Subjects

NCT05592262 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-12-19

No results posted yet for this study

Summary

The objective of the study is to assess the effect of food on the pharmacokinetics, and safety of SHR2554 Tablets in healthy subjects.

Conditions

  • Malignant Tumor

Interventions

DRUG

SHR2554

On an empty stomach - after meals

DRUG

SHR2554

After meals - on an empty stomach

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-15
Primary Completion
2022-12-14
Completion
2022-12-14

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05592262 on ClinicalTrials.gov